Abstract
Patients with the acquired immunodeficiency syndrome (AIDS) are characterized by a decrease in the number of T helper cells, a defect that is linked to the impaired immunologic competence. Vitamin A and its dietary precursor, beta-carotene, increase absolute T helper cell counts as well as indices of T cell function in both human and animal models. To determine if short-term beta-carotene treatment affects T lymphocyte subsets in patients with AIDS, a single-blind, non-randomized clinical trial of beta-carotene was performed in seven patients with AIDS. Enrollment criteria included no evidence of: a) active opportunistic infection: b) greater than 1 kilogram change in weight in the month preceding enrollment; c) chronic diarrhea or malabsorption; and d) hepatic disease or significant anemia. Beta-carotene was given with meals in two divided doses of 60 mg/day for four weeks; this was followed by no therapy for six weeks. Samples for total white blood cell, lymphocyte and T lymphocyte subset counts were measured at baseline, at the end of four weeks of treatment and another six weeks after treatment had stopped. P24 antigen, beta-2 microglobulin and liver function tests were also measured. All subjects tolerated the treatment well without evidence of toxicity. In response to beta-carotene, total lymphocyte counts rose by 66 percent (.05 < p < .10), and CD4+ cells rose slightly, but insignificantly, in the entire group. In all three of the patients who had baseline CD4+ cells greater than 10/microliters, however, the mean absolute increase in CD4+ cells in response to beta-carotene was 53 +/- 10 cells/microliters (p < .01). Six weeks off beta-carotene treatment, the absolute CD4+ cell count returned to pretreatment levels (p < .01). No change was observed in CD8+ cells. P24 antigen and beta-2 microglobulin did not change during treatment. These preliminary observations suggest that short-term treatment with beta-carotene may increase CD4+ cell counts in patients with AIDS who have greater than 10 cells/microliters.
Full text
PDF




Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Alexander M., Newmark H., Miller R. G. Oral beta-carotene can increase the number of OKT4+ cells in human blood. Immunol Lett. 1985;9(4):221–224. doi: 10.1016/0165-2478(85)90036-7. [DOI] [PubMed] [Google Scholar]
- Bianchi-Santamaria A., Fedeli S., Santamaria L. Short communication: possible activity of beta-carotene in patients with the AIDS related complex. A pilot study. Med Oncol Tumor Pharmacother. 1992;9(3):151–153. doi: 10.1007/BF02987747. [DOI] [PubMed] [Google Scholar]
- Cohen B. E., Elin R. J. Vitamin A-induced nonspecific resistance to infection. J Infect Dis. 1974 May;129(5):597–600. doi: 10.1093/infdis/129.5.597. [DOI] [PubMed] [Google Scholar]
- Cohen B. E., Gill G., Cullen P. R., Morris P. J. Reversal of postoperative immunosuppression in man by vitamin A. Surg Gynecol Obstet. 1979 Nov;149(5):658–662. [PubMed] [Google Scholar]
- Coodley G. O., Nelson H. D., Loveless M. O., Folk C. Beta-carotene in HIV infection. J Acquir Immune Defic Syndr. 1993 Mar;6(3):272–276. [PubMed] [Google Scholar]
- Fawzi W. W., Chalmers T. C., Herrera M. G., Mosteller F. Vitamin A supplementation and child mortality. A meta-analysis. JAMA. 1993 Feb 17;269(7):898–903. [PubMed] [Google Scholar]
- Garewal H. S., Ampel N. M., Watson R. R., Prabhala R. H., Dols C. L. A preliminary trial of beta-carotene in subjects infected with the human immunodeficiency virus. J Nutr. 1992 Mar;122(3 Suppl):728–732. doi: 10.1093/jn/122.suppl_3.728. [DOI] [PubMed] [Google Scholar]
- Hathcock J. N., Hattan D. G., Jenkins M. Y., McDonald J. T., Sundaresan P. R., Wilkening V. L. Evaluation of vitamin A toxicity. Am J Clin Nutr. 1990 Aug;52(2):183–202. doi: 10.1093/ajcn/52.2.183. [DOI] [PubMed] [Google Scholar]
- Malkovský M., Edwards A. J., Hunt R., Palmer L., Medawar P. B. T-cell-mediated enhancement of host-versus-graft reactivity in mice fed a diet enriched in vitamin A acetate. Nature. 1983 Mar 24;302(5906):338–340. doi: 10.1038/302338a0. [DOI] [PubMed] [Google Scholar]
- Malkovský M., Medawar P. B., Thatcher D. R., Toy J., Hunt R., Rayfield L. S., Doré C. Acquired immunological tolerance of foreign cells is impaired by recombinant interleukin 2 or vitamin A acetate. Proc Natl Acad Sci U S A. 1985 Jan;82(2):536–538. doi: 10.1073/pnas.82.2.536. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Phair J., Muñoz A., Detels R., Kaslow R., Rinaldo C., Saah A. The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group. N Engl J Med. 1990 Jan 18;322(3):161–165. doi: 10.1056/NEJM199001183220304. [DOI] [PubMed] [Google Scholar]
- Seifter E., Rettura G., Padawer J., Demetriou A. A., Levenson S. Antipyretic and antiviral action of vitamin A in Moloney sarcoma virus- and poxvirus-inoculated mice. J Natl Cancer Inst. 1976 Aug;57(2):355–359. doi: 10.1093/jnci/57.2.355. [DOI] [PubMed] [Google Scholar]
- Semba R. D., Graham N. M., Caiaffa W. T., Margolick J. B., Clement L., Vlahov D. Increased mortality associated with vitamin A deficiency during human immunodeficiency virus type 1 infection. Arch Intern Med. 1993 Sep 27;153(18):2149–2154. [PubMed] [Google Scholar]
- Ullrich R., Schneider T., Heise W., Schmidt W., Averdunk R., Riecken E. O., Zeitz M. Serum carotene deficiency in HIV-infected patients. Berlin Diarrhoea/Wasting Syndrome Study Group. AIDS. 1994 May;8(5):661–665. doi: 10.1097/00002030-199405000-00013. [DOI] [PubMed] [Google Scholar]
- Watson R. R., Prabhala R. H., Plezia P. M., Alberts D. S. Effect of beta-carotene on lymphocyte subpopulations in elderly humans: evidence for a dose-response relationship. Am J Clin Nutr. 1991 Jan;53(1):90–94. doi: 10.1093/ajcn/53.1.90. [DOI] [PubMed] [Google Scholar]
